XORTX Therapeutics XRTX
NASDAQ XRTX
$0.93 -0.06 (-6.05%)
At close: Oct 21, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Short term Debt (2023 - 2026)

Updated

XORTX Therapeutics (XRTX) posted Short term Debt of $61,536 for the quarter ended Mar 31, 2023, down 6.7% from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Short term Debt (2023 - 2026) Analysis & Trends

As of Dec 31, 2022, XORTX Therapeutics' Short term Debt came in at $68,853.

  • According to Business Quant data, Short term Debt for the three prior quarters was $65,947 (quarter ended Dec 31, 2022), $67,333 (quarter ended Sep 30, 2022) and $67,556 (quarter ended Jun 30, 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 XORTX Therapeutics 893,236.25 -2.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -15,056.00
Dec 31, 2025 -37,287.00
Sep 30, 2025 -59,094.00
Mar 31, 2025 -15,662.00
Dec 31, 2023 -8,700.19
API Access

XORTX Therapeutics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=XRTX&period=max&api_key=YOUR_API_KEY